SCHEMBL13699818

SCHEMBL13699818

Cc1ccc(C(=O)Nc2c(C(N)=O)oc3cc(Cl)ccc23)o1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.55
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
HSD17B10 Q99714 4/20 0.47
MAPK10 P53779 3/20 0.47
TP53 P04637 2/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
MCL1 Q07820 1/20 0.46
ALDH1A1 P00352 2/20 0.45
HPGD P15428 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
TSHR P16473 2/20 0.45
KLK7 P49862 1/20 0.45
APOBEC3A P31941 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
S1PR4 O95977 4/20 0.43
S1PR2 O95136 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699817 0.91 KDM4E (0.68) KDM4EMEN1KMT2AHSD17B10MAPK10
SCHEMBL13699822 0.85 KDM4E (0.52) KDM4EMEN1KMT2AHSD17B10MAPK10
SCHEMBL13699819 0.84 HPGD (0.59) KDM4EMEN1KMT2AHSD17B10MAPK10
SCHEMBL13700051 0.84 KDM4E (0.50) KDM4EMEN1KMT2AHSD17B10MAPK10
SCHEMBL13700235 0.83 KDM4E (0.49) KDM4EMEN1KMT2AHSD17B10MAPK10
SCHEMBL13699828 0.82 S1PR4 (0.51) KDM4EMEN1KMT2AHSD17B10MAPK10
SCHEMBL13699712 0.82 ALDH1A1 (0.60) KDM4EMEN1KMT2AHSD17B10MAPK10
SCHEMBL13700232 0.81 KDM4E (0.47) KDM4EMEN1KMT2AHSD17B10MAPK10
SCHEMBL13700073 0.81 KCNH2 (0.56) KDM4EMEN1KMT2ATP53ALDH1A1
SCHEMBL13699740 0.81 ALDH1A1 (0.53) KDM4EMEN1KMT2AHSD17B10MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885MEN1 4409/4885KMT2A 2861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.